These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 13326838)

  • 21. Ganglionic blocking agents with special reference to the effect of hexamethonium on the cardiovascular system.
    PATON WD
    Br Med Bull; 1952; 8(4):310-5. PubMed ID: 12987688
    [No Abstract]   [Full Text] [Related]  

  • 22. [The electrolytes in congestive heart failure].
    GAUNA EF
    Rev Asoc Med Argent; 1956 Jun 15-30; 70(821-822):152-8. PubMed ID: 13350650
    [No Abstract]   [Full Text] [Related]  

  • 23. [Water and electrolyte metabolism in cardiac decompensation].
    LAMBIC IS
    Med Glas; 1953 Jan; 7(1):11-5. PubMed ID: 13054268
    [No Abstract]   [Full Text] [Related]  

  • 24. Studies on cholinergic-blocking substances. VI. The pharmacology of hexamethonium- and pendiomid type ganglionic-blocking compounds.
    GYERMEK L
    Acta Physiol Acad Sci Hung; 1954; 5(1-2):163-79. PubMed ID: 13147923
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrolyte disturbances associated with mercurial diuretic therapy in congestive heart failure.
    HOLLEY HL; HOGAN RS
    Int Rec Med Gen Pract Clin; 1953 Oct; 166(10):415-9. PubMed ID: 13108358
    [No Abstract]   [Full Text] [Related]  

  • 26. The effect of cardiac oedema formation on electrolyte and water metabolism.
    CORT JH
    Acta Med Acad Sci Hung; 1955; 8(3-4):347-67. PubMed ID: 13301363
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of a ganglion-blocking agent, hexamethonium bitartrate on the induction of experimental erythema in guinea pigs and man].
    PANCONESI E
    Rass Dermatol Sifilogr; 1955; 8(3):149-74. PubMed ID: 13290051
    [No Abstract]   [Full Text] [Related]  

  • 28. The effects of intravenous hexamethonium on venous pressure of normotensive and hypertensive patients with and without congestive heart failure.
    BURCH RR
    Circulation; 1955 Feb; 11(2):271-9. PubMed ID: 13231264
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of trimethidinium methosulfate (a new ganglionic blocking agent) in the treatment of hypertension.
    BORHANI NO
    Ann Intern Med; 1959 Nov; 51():983-92. PubMed ID: 13802828
    [No Abstract]   [Full Text] [Related]  

  • 30. [ON ION TRANSPORT BEFORE AND AFTER TREATMENT OF CONGESTIVE HEART FAILURE].
    OZDOGAN E
    Turk Tip Cemiy Mecm; 1963 Nov; 29():630-9. PubMed ID: 14100587
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrolytes and congestive failure.
    DANOWSKI TS
    Ann Intern Med; 1952 Sep; 37(3):453-64. PubMed ID: 12976943
    [No Abstract]   [Full Text] [Related]  

  • 32. The interrelationships of the cardiovascular, renal and electrolyte effects of intravenous digoxin in congestive heart failure.
    EICHNA LW; FARBER SJ; BERGER AR; EARLE DP; RADER B; PELLEGRINO E; ALBERT RE; ALEXANDER JD; TAUBE H; YOUNGWIRTH S
    J Clin Invest; 1951 Nov; 30(11):1250-61. PubMed ID: 14888703
    [No Abstract]   [Full Text] [Related]  

  • 33. [TREATMENT OF HYPERTENSION WITH GANGLIONIC-BLOCKING AGENTS IN ELDERLY AND AGED PATIENTS].
    DRACHEVA ZN
    Klin Med (Mosk); 1964 Jan; 42():41-7. PubMed ID: 14150098
    [No Abstract]   [Full Text] [Related]  

  • 34. Electrolyte disturbances in congestive heart failure: clinical significance and management.
    SCHWARTZ WB; RELMAN AS
    J Am Med Assoc; 1954 Apr; 154(15):1237-41. PubMed ID: 13151829
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of a head-up tilted position and ambulation on renal hemodynamics and water and electrolyte excretion in patients with hypertension, with and without renal damage.
    MOYER JH; MILLS LC; FORD RV; SPURR C
    J Lab Clin Med; 1955 Feb; 45(2):179-90. PubMed ID: 13233645
    [No Abstract]   [Full Text] [Related]  

  • 36. Drug therapy (mecamylamine) of hypertension. III. Results with mecamylamine, a completely absorbed ganglionic blocking agent.
    CAPLOVITZ C; CONNER PK; DENNIS E; FORD R; HERSHBERGER R; KINARD S; MCCONN R; MOYER JH
    AMA Arch Intern Med; 1956 Aug; 98(2):187-210. PubMed ID: 13354014
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of blood pressure reduction with arfonad on renal hemodynamics and the excretion of water and electrolytes in patients with hypertension.
    MOYER JH; McCONN R; SEIBERT RA
    Am Heart J; 1955 Mar; 49(3):360-6. PubMed ID: 14349851
    [No Abstract]   [Full Text] [Related]  

  • 38. Induction of neurally mediated NaHCO3 secretion by luminal distension in rat ileum.
    Harris MS; Ramaswamy K; Kennedy JG
    Am J Physiol; 1989 Aug; 257(2 Pt 1):G191-7. PubMed ID: 2569830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urinary elimination of water and electrolytes in patients with congestive cardiac insufficiency of different etiologies treated with hygieno-dietetic therapy and cardiotonics. II].
    Tacu V; Arghir A; Scripcaru G; Cosma M; Hodan O; Covic M
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(2):305-11. PubMed ID: 5801968
    [No Abstract]   [Full Text] [Related]  

  • 40. ACUTE INFUSION OF SYNTHETIC ANGIOTENSIN II IN PATIENTS WITH ESSENTIAL HYPERTENSION. ITS EFFECT ON RENAL HEMODYNAMICS AND ON ELECTROLYTE AND WATER EXCRETION.
    VAGNUCCI AI; LAULER DP; HICKLER RB; THORN GW
    Circulation; 1964 Apr; 29():SUPPL:523-32. PubMed ID: 14137487
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.